Macrophage-secreted factors decrease RBP4 production. by Primoz Kotnik (382835)

MPI knockdown decreases migration of human glioblastoma cells. by Aurélie Cazet (644004)

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…(D) The level of REST dramatically reduced in differentiated SH-SY5Y cells treated with GA (1 μM) or PU-H71 (50 nM) at 24 h. (E) The REST level decreased by GA more than 50% and (F) PU-H71 more than 80%, respectively. …”

miR-24 levels decrease with replicative senescence. by Ashish Lal (43926)

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

Ade decreases cell viability and induces cell death. by Shujue Li (466324)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…At each interval, we obtained (<b>A</b>) microscopic images (original magnification: 100x), (<b>B</b>) AFM topography images (scan size <b>B1</b>, 50 µm; <b>B2</b>, 20 µm; <b>B3</b>, 33.3 µm), and (<b>C</b>) height measurements at the cross section of an individual cell. …”

Cellular input resistance is decreased during UP states. by Brendon O. Watson (268774)

“…Mean decrease was 50.9%; standard deviation was 36.6%, shown in gray bar at left. 2 of 4 interneurons showed significant decreases in resistance during the UP state and one cell actually showed an increase. …”

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Klotho decreased the expression of GRP78 in mouse heart. by Shuang Song (457799)

Klotho decreased the expression of HSP47 in mouse heart. by Shuang Song (457799)

Resveratrol decreased intracellular levels of R5P. by Mohd Askandar Iqbal (324124)

“…Approximately 20–25% decrease in intracellular levels of R5P in HeLa and HepG2 was observed upon 50 µM resveratrol treatment. …”

Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

“…MTT cell viability assay:</b> VCaP cells were transfected with siRNA TMPRSS2-ERG III (1, 2), TMPRSS2-ERG IV (1) and siRNA Control at 50 nM concentration and incubated for 72h. Bars represent mean ± SD of 2 independent experiments containing 8 replicates for each condition. …”

Decreased fibrin deposition in hypoxic C3−/− mice. by Eileen M. Bauer (337320)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Calyculin A-induced decrease of tyrosine-monophosphorylated ERK2 at high cell density. by Noriyuki Kawabata (3391739)

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”

Effects of siRNA TMPRSS2-ERG III and IV on cell death pathways. by Giorgia Urbinati (554921)

Silencing of dynamin II decreases apoE secretion. by Maaike Kockx (154125)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”